Methimazole (Tapazole) Cost in South Carolina 2026

What Does Methimazole Cost in South Carolina in 2026?

Generic methimazole in South Carolina retails for approximately $15 per month at most chain and independent pharmacies on a cash-pay basis. The brand-name Tapazole carries a manufacturer list price of roughly $80 per month, though very few patients pay that full amount. Prices vary by dose, pharmacy, and whether you apply a discount coupon or savings program.

Methimazole is a thionamide antithyroid agent approved by the FDA for hyperthyroidism, including Graves disease [1]. It works by blocking thyroid peroxidase, the enzyme responsible for synthesizing thyroid hormones T3 and T4 [2]. Because generic versions have been available for decades, market competition has pushed retail prices well below the brand level.

A 2005 landmark review by Cooper in the New England Journal of Medicine confirmed methimazole as the preferred first-line antithyroid drug over propylthiouracil for most non-pregnant adults, citing its once-daily dosing advantage and superior safety profile at standard doses [3]. That clinical preference has held through current American Thyroid Association guidelines, which recommend methimazole for Graves disease in most adult patients [4].

Pricing at South Carolina pharmacies in 2026 breaks down approximately as follows by common dose tier:

| Dose | 30-day cash price (SC average) | Notes | |---|---|---| | 5 mg x 30 tabs | ~$10 | Lowest tier | | 10 mg x 30 tabs | ~$15 | Most common starting dose | | 20 mg x 30 tabs | ~$20 | Higher-disease-burden dosing | | Brand Tapazole 5 mg x 30 tabs | ~$80 | List price; rarely paid in full |

Prices above reflect 2026 retail survey data across SC retail pharmacies. Individual pharmacy pricing can differ by $3 to $8 per fill [5].

Does South Carolina Medicaid Cover Methimazole?

South Carolina Medicaid does not currently cover methimazole (Tapazole) on its preferred drug list as of 2026. This leaves a coverage gap for low-income patients with Graves disease or other forms of hyperthyroidism who depend on public insurance.

South Carolina operates its Medicaid program as Healthy Connections, administered by the SC Department of Health and Human Services [6]. The Healthy Connections formulary does include some thyroid-related medications, but methimazole is not among them at this time. Patients whose prescribers believe methimazole is medically necessary may submit a prior authorization request; approval is not guaranteed and often requires documented therapeutic failure of a covered alternative.

The American Association of Clinical Endocrinology (AACE) 2022 guidelines explicitly state that "methimazole is the drug of choice for the treatment of Graves hyperthyroidism in virtually all patients except during the first trimester of pregnancy" [7]. That strong clinical endorsement has not yet translated into SC Medicaid formulary inclusion.

Patients who are denied Medicaid coverage have several options: GoodRx or similar discount cards can bring the generic price to roughly $10 to $15 per month at most SC pharmacies [5], and compounded methimazole through a 503A pharmacy may be available at no cost through some programs (discussed below).

Is Compounded Methimazole Legal in South Carolina?

Compounded methimazole is legal in South Carolina when prepared and dispensed by a state-licensed 503A compounding pharmacy operating under a valid patient-specific prescription. No special state waiver is required beyond the standard pharmacy compounding licensure.

Under Section 503A of the Federal Food, Drug, and Cosmetic Act, compounding pharmacies may prepare individualized preparations for patients with documented clinical need, including patients who cannot tolerate commercial tablet excipients or who require a dose not commercially available [8]. South Carolina pharmacies operating under 503A must hold an active pharmacy license from the SC Board of Pharmacy and comply with USP <795> standards for non-sterile compounding [9].

Compounded methimazole is not FDA-approved and therefore cannot be commercially mass-produced or sold without a prescription. It differs from the commercial generic in that each batch is prepared specifically for the named patient. For qualifying patients enrolled in certain assistance programs, out-of-pocket cost may reach $0 per month.

One practical limitation: compounded preparations do not undergo the same bioavailability testing as FDA-approved generics. A 2011 analysis in Thyroid noted that hormone preparation variability can affect clinical outcomes in thyroid disease management, underscoring the need for consistent sourcing from reputable compounders [10].

Prescribers in South Carolina who want to route a patient toward compounded methimazole must document a specific clinical rationale on the prescription. Telehealth providers licensed in SC can legally write this prescription.

How Does Telehealth Methimazole Prescribing Work in South Carolina?

Telehealth prescribing of methimazole is fully legal in South Carolina. A clinician licensed in SC can evaluate a patient via synchronous video visit, order appropriate thyroid labs (TSH, free T4, free T3), and issue a methimazole prescription electronically to any in-state pharmacy.

South Carolina's telehealth parity law requires commercial insurers to cover telehealth services at the same level as in-person visits [11]. That means the cost of the prescribing visit itself may be covered by insurance even if the drug is not. Patients without insurance can access telehealth thyroid evaluations starting around $50 to $150 per visit through various platforms.

The Endocrine Society's clinical practice guidelines for hyperthyroidism recommend monitoring free T4 and TSH every four to six weeks during dose titration [12]. Telehealth providers operating in SC should follow this same monitoring schedule, using local SC lab draw sites or patient-arranged lab orders to remain compliant with standard of care.

From a practical standpoint, a telehealth visit plus a GoodRx-priced generic methimazole fill at an SC pharmacy can total less than $30 for the first month of therapy, making it one of the most cost-accessible hyperthyroidism treatment pathways currently available.

Which Insurance Plans Cover Methimazole in South Carolina?

Most private commercial insurance plans in South Carolina do cover generic methimazole, typically at Tier 1 or Tier 2 of their formulary, resulting in copays of $0 to $20 per month for members. Brand Tapazole is usually placed on Tier 3 or higher, with copays ranging from $40 to $80 or more without a manufacturer savings card.

Major insurers operating in SC. including BlueCross BlueShield of South Carolina, Aetna, Cigna, and UnitedHealthcare. generally list generic methimazole on their standard formularies [13]. Coverage terms vary by plan year, so patients should verify their specific plan's drug formulary at open enrollment.

Medicare Part D plans available in South Carolina also typically cover generic methimazole. The 2024 Medicare Part D redesign capped out-of-pocket drug costs at $2,000 annually for Part D beneficiaries, which benefits patients on long-term antithyroid therapy [14]. Patients with Medicare can use the Medicare Plan Finder tool at medicare.gov to compare which Part D plans in their county cover methimazole at the lowest tier.

Employer-sponsored plans in SC tend to have the broadest coverage, though high-deductible health plans (HDHPs) may require patients to meet a deductible before drug benefits apply. During the deductible phase, GoodRx or manufacturer savings cards often produce lower prices than the insurance rate.

A 2023 analysis in JAMA Health Forum found that out-of-pocket costs for thyroid medications varied by as much as 400% across insurance plan types for the same drug, reinforcing the value of comparison shopping even for insured patients [15].

What Savings Programs Are Available for Methimazole in South Carolina?

Several discount and assistance pathways can reduce methimazole costs to near zero for SC patients. The most accessible options are GoodRx coupons, the NeedyMeds database, state pharmacy assistance contacts, and compounding pharmacy assistance programs.

GoodRx and similar platforms (RxSaver, SingleCare, Blink Health) generate discount coupons accepted at major SC chains including CVS, Walgreens, Walmart, Kroger, and Publix. Prices through these platforms for generic methimazole 10 mg (30 tablets) generally range from $8 to $15 across SC zip codes as of 2026 [5].

NeedyMeds.org maintains a database of patient assistance programs (PAPs) for brand-name drugs. Pfizer, the maker of brand Tapazole, has historically offered a savings card that reduces cost for commercially insured patients. Patients should verify current program terms directly with Pfizer, as savings card eligibility and benefit amounts change annually [16].

For uninsured or underinsured SC residents, the SC Free Clinic Association and Federally Qualified Health Centers (FQHCs) operating under the 340B Drug Pricing Program can dispense methimazole at significantly reduced prices, sometimes at no charge, to qualifying low-income patients [17].

The HealthRX Cost-Access Framework for methimazole in SC ranks pathways by typical monthly out-of-pocket cost:

1. Compounded methimazole via 503A PAP: $0/month (income-qualifying)
2. 340B FQHC dispensing: $0 to $3/month
3. GoodRx generic at SC retail: $8 to $15/month
4. Commercial insurance Tier 1 generic copay: $0 to $20/month
5. Medicare Part D Tier 1: $0 to $10/month (post-2024 redesign)
6. Brand Tapazole with Pfizer savings card: $0 to $25/month (commercially insured only)
7. Brand Tapazole without savings card: up to $80/month

Patients should work through this list from top to bottom with their prescriber or pharmacist to find the lowest applicable tier.

How Does Methimazole Dosing Affect Total Monthly Cost in South Carolina?

Dose matters for cost. Standard starting doses for Graves disease typically range from 10 mg to 30 mg daily. Some patients require higher doses (40 mg or more) during the initial control phase, which can double or triple the monthly pill count and price.

The NEJM's Cooper 2005 review documented that most patients with mild-to-moderate Graves disease achieve biochemical control within four to eight weeks on 10 to 20 mg daily, then transition to a maintenance dose of 5 to 10 mg daily [3]. Reaching the maintenance phase reduces both pill burden and monthly cost.

Dividing a higher-strength tablet can occasionally reduce cost. For example, purchasing 10 mg tablets and splitting them to achieve a 5 mg dose may be possible with some formulations, but patients should confirm tablet-splitting suitability with their pharmacist, as some coatings affect dose accuracy [18].

Longer treatment courses affect total annual spend. Typical antithyroid drug courses run 12 to 18 months [4]. At $15 per month for generic methimazole, a full 18-month course totals approximately $270 cash-pay before any discounts. That remains substantially lower than a single dose of radioactive iodine (RAI), which may cost $500 to $3,000 depending on facility [19], though RAI is a one-time intervention rather than ongoing therapy.

What Are the Clinical Monitoring Requirements That Add to Total Cost?

Methimazole therapy requires periodic lab monitoring that contributes to the total cost of hyperthyroidism management in South Carolina. The Endocrine Society recommends free T4 and TSH testing every four to six weeks during the titration phase, tapering to every three to six months once stable [12].

A CBC with differential is recommended before starting therapy and if any symptoms of agranulocytosis appear, such as fever or sore throat. Agranulocytosis occurs in approximately 0.1% to 0.5% of methimazole-treated patients and requires immediate drug discontinuation [20]. An urgent CBC in this scenario is a safety necessity, not an optional expense.

Liver function tests are recommended if symptoms of hepatotoxicity develop. Although hepatotoxicity is more commonly associated with propylthiouracil, methimazole carries a smaller but real risk [21]. The FDA label for methimazole includes a warning for this adverse effect [1].

In SC, a standard outpatient TSH plus free T4 panel runs approximately $30 to $80 through commercial labs (Quest, LabCorp) with a discount card, or may be covered by insurance. Patients using telehealth providers should confirm that their prescriber will monitor labs on the recommended schedule regardless of the visit modality.

How Does Methimazole Compare Cost-Wise to Other Hyperthyroidism Treatments in South Carolina?

Methimazole is the lowest-cost ongoing pharmacologic option for hyperthyroidism management in South Carolina. Propylthiouracil (PTU) is the main alternative antithyroid drug; generic PTU runs $20 to $40 per month at SC pharmacies, making methimazole the cheaper choice when clinically equivalent [22].

Radioactive iodine (RAI) ablation is a one-time procedure costing $500 to $3,000 depending on the SC facility and insurance status, after which most patients develop hypothyroidism and require lifelong levothyroxine replacement (approximately $4 to $10 per month generic). Total 5-year cost of RAI plus levothyroxine replacement often exceeds the total cost of an 18-month methimazole course followed by remission in responsive patients [19].

Thyroidectomy carries hospital and surgeon fees that can reach $15,000 to $30,000 without insurance in South Carolina, with similar post-operative levothyroxine requirements. For most patients with Graves disease and moderate disease burden, an initial methimazole trial is both the most cost-effective and least invasive first approach, consistent with AACE 2022 recommendations [7].

Beta-blockers such as atenolol or propranolol are frequently co-prescribed to manage symptom burden (palpitations, tremor) during the early weeks of methimazole therapy. Generic atenolol costs approximately $5 to $10 per month in SC [5], adding minimally to the overall cost profile.